Future perspectives on regulating pro-and anti-inflammatory responses in sepsis

Area of Science:

• Critical care medicine
• Infectious diseases
• Pharmacology

Background:

• Severe sepsis and septic shock represent a significant unmet medical need.
• Current treatments are largely supportive, including antibiotics, fluid resuscitation, and organ support.
• Disordered inflammatory responses are central to sepsis-induced organ failure.

Purpose of the Study:

• To review current and emerging therapeutic strategies for severe sepsis and septic shock.
• To discuss agents targeting microbial mediators, inflammation, coagulation, and novel pathways.
• To present the current status of these investigational agents.

Main Methods:

• Literature review of current agents and pathways investigated for sepsis treatment.
• Categorization of therapies based on targeted mechanisms (microbial mediators, inflammation, coagulation, novel pathways).
• Analysis of the current status of these investigational treatments.

Main Results:

• Numerous molecules and devices target bacterial mediators like endotoxin and superantigens.
• Therapeutic strategies include restoring anticoagulation, blocking complement, preserving mitochondria, and inhibiting apoptosis.
• Investigational agents with pluripotent activity and those promoting microbial clearance and immune reconstitution are explored.

Conclusions:

• Developing novel treatments to regulate the inflammatory response in sepsis is essential for improving outcomes.
• Targeting microbial mediators, inflammation, coagulation, and novel pathways offers promising avenues for sepsis therapy.
• Continued research into these diverse therapeutic strategies is critical for addressing the unmet medical need in sepsis and septic shock.